Invisalign Itero

Board of Directors

C. Raymond Larkin, Jr.
Ray Larkin Photo
Independent Director Chairman of the Board
1999 - 2010 Principal, Group Outcome L.L.C. (merchant banking)
2003 - 2007 CEO, Eunoe, Inc. (medical device company)
Prior Venture Partner, Venture Partner at Cutlass Capital (venture capital firm)
  President and CEO, Nellcor Puritan Bennett, Inc.
(respiratory products companies)

Other Board Positions
Shockwave Medical, Inc., Chair (2019-present)
Neuropace (2008-2019)
Heartware, Inc., Chair (2008-2018)
Reva Medical, Inc., Chair (2008-2018)

Notable Experience and Key Board Contributions

  • Mr. Larkin brings significant leadership experience at large public companies, a deep knowledge and authority in the medical device and healthcare fields, extensive public and private company board experience, and strong strategic business development and tactical implementation skills.
  • Mr. Larkin has unique experience with the growth and maturation of a medical device company. He grew Nellcor to nearly $1 billion in revenues through the development and introduction of pulse oximetry into worldwide use for patient safety monitoring, setting the standard of care for the respiratory-impaired patient.
  • Mr. Larkin served in the United States Marine Corps, rising to the level of Captain.

B.S. in Industrial Management from LaSalle University

Kevin Conroy
Independent Director
2009 - Present CEO and Chairman of the Board (2014), Exact Sciences
  Corp. (molecular diagnostics company) 
2005 - 2008 President and CEO, Third Wave Technologies, Inc.
  (molecular diagnostics company) 
2004 - 2005 General Counsel, Third Wave Technologies, Inc.
  (molecular diagnostics company) 
Prior Various Leadership Positions at GE Healthcare
  (medical technology company) 

Other Board Positions
Adaptive Biotechnologies Corporation (2019-2023)
Epizyme, Inc. (2017-2022)
CM Life Sciences II Inc. (2021)
SomaLogic, Inc. (2021)
Arya Sciences Acquisition Corp. (2018-2020)

Notable Experience and Key Board Contributions

  • Mr. Conroy has extensive experience creating stockholder value as a business, legal, corporate strategy, and executive leader and has significant experience in the healthcare and the molecular diagnostics industries.
  • At Exact Sciences, Mr. Conroy has developed Cologuard and the company has grown to $2.5B in revenue while serving 4 million patients.
  • At Third Wave, Mr. Conroy developed and brought a novel cervical cancer screening test, Cervista, to patients.

B.S. in Electrical Engineering from Michigan State University
J.D. from the University of Michigan Law School

Kevin J. Dallas
Kevin J. Dallas
Independent Director
Chair of the Technology
2023 - Present CEO, EnterpriseDB Corporation (software company)
2020 - 2022 CEO, Wind River Systems, Inc. (software company)
1996 - 2020 Corporate Vice President, Cloud & AI Business
  Development, Microsoft (software company)
Prior Various Positions, NVIDIA Corporation and
  National Semiconductor, now Texas Instruments Inc.
  (technology company)

Notable Experience and Key Board Contributions

  • Mr. Dallas brings more than 25 years of experience driving digital innovation and growth at technology companies and expertise in the digital transformation of customers and partners.
  • At Microsoft, Mr. Dallas enabled the digital transformation of customers and partners across a range of industries including: connected/autonomous vehicles, industrial IoT, discrete manufacturing, retail, financial services, media and entertainment, and healthcare.

B.S.c. in Electrical and Electronic Engineering from Staffordshire University

Joseph M. Hogan
Director, President and CEO of Align Technology, Inc.
2015 - Present President and CEO, Align Technology Inc. (dental technology 
Prior CEO, ABB at Cutlass Capital (technology company)
  Various Positions including CEO of GE Healthcare, 
  General Electric (a medical technology company)

Other Board Positions
Supervisory Board of avateramedical N.V. (2019-2021)

Notable Experience and Key Board Contributions

  • At Align, Mr. Hogan has overseen significant financial and operating performance over the last eight years.
  • Mr. Hogan is a proven leader serving as an integral connection between our board of directors and management. He brings to Align significant leadership experience from large public companies, with strategic business, market development and sales acumen, and expertise in strategic and operational aspects of complex, international organizations.
  • During his five years at ABB, Mr. Hogan oversaw a 25% increase in revenues.
  • As CEO of GE Healthcare, Mr. Hogan drove significant geographic and market portfolio expansion and more than doubled revenues from $7 billion to $16 billion.

B.S. in Business and Economics from Geneva College
M.B.A. from Robert Morris University

Joseph Lacob
Joe Lacob Photo
Independent Director
Member of the Technology
2010 - Present Governor, Co-Executive Chairman and CEO,
  Golden State Warriors (basketball team) and
  Golden State WNBA (basketball team)
1987 - 2010 Partner, Kleiner Perkins Caufield & Byers
  (venture capital firm)
Prior Various Positions, Cetus Corporation, now Chiron
  Corporation (biotechnology company)
  Various Positions, FHP International (health maintenance organization)
  Various Positions, Booz, Allen & Hamilton (consulting firm

Other Board Positions
Golden State Warriors (2010-present) 
NeuroPace, Inc. (1997-present)
Orexigen Therapeutics, Inc. (2004-2012)

Notable Experience and Key Board Contributions

  • Mr. Lacob brings expertise in evaluating and developing strategic opportunities, specifically in the technology, healthcare and life sciences industries. 
  • Mr. Lacob also has significant consumer marketing, financial, strategic investment and mergers and acquisition experience.
  • Mr. Lacob was closely involved with KPCB's investments in more than 50 life science companies, including the startup or incubation of a dozen ventures, and with KPCB's medical technology practice, which includes more than 30 therapeutic and diagnostic medical device companies.

B.S. in Biological Sciences from the University of California at Irvine
Masters in public health from the University of California at Los Angeles
M.B.A. from Stanford University

George J. Morrow
2003 - 2011 Executive Vice President, Global Commercial Operations,
  Amgen Inc. (biotechnology company)
2001 - 2003 Executive Vice President of Worldwide Sales and Marketing,
  Amgen Inc. (biotechnology company)
Prior Various Positions including President and Chief Executive 
  Officer of Glaxo Wellcome Inc., GlaxoSmithKline Inc.
  (biopharma  company)

Other Board Positions
Neurocrine Biosciences, Inc. (2015-present)
Vical, Inc. (2012-2019)
Otonomy, Inc. (2015-2018)  
Human Genome Sciences, Inc.
Glaxo Wellcome, Inc. 
Safeway, Inc. 
National Commerce Bank

Notable Experience and Key Board Contributions

  • Mr. Morrow brings significant leadership experience in sales, marketing and operational global ownership, a valuable understanding of medical device regulatory and compliance, financial, and corporate governance, and expertise in growth driven sales compensation strategies and risk mitigation controls.
  • As Executive Vice President of Amgen, Mr. Morrow oversaw all commercial functions for Amgen's broad spectrum of products in more than 50 countries.

B.S. in Chemistry from Southampton College, Long Island University
M.B.A. from Duke University
M.S. in Biochemistry from Bryn Mawr College 

Anne M. Myong
Anne Myong
Independent Director
2021 - 2023 President, Amyris, Inc. (biotechnology company)
2020 - 2021 Chief Executive Officer and Chief Financial Officer,
  Aura Financial (financial services company)
2014 - 2017 Senior Vice President and Chief Financial Officer,
  Walmart Global eCommerce (eCommerce segment of
  retail corporation) 
2011 - 2014 Senior Vice President, Chief Financial and Administrative Officer, 
  Walmart China Retail (retail corporation)
Prior Vice President and Chief Financial Officer, Agilent Technologies
  China (life science software and supplies company)

Other Board Positions
Goodwill Industries International, Inc. (2016-2022)

Notable Experience and Key Board Contributions

  • Ms. Myong brings extensive experience in global operations, finance and accounting with a unique knowledge of international markets, a deep understanding of financial reporting and organizational risks, controls and monitoring, and expertise in consumer products, omnichannel retailing, digital marketing, and scaling industry-transforming innovations.
  • As Senior Vice President and Chief Financial Officer of Walmart Global eCommerce, Ms. Myong accelerated the growth, profitability, and digital transformation of Walmart’s retail and e-commerce operations in the United States, China, and Brazil.

B.B.A. in Computer Information Systems from James Madison University
M.B.A. from Harvard Business School 

Mojdeh Poul
Mojdeh Poul
Independent Director
2019 - 2022 Executive Vice President and Group President, 3M Healthcare 
  Business Group (global healthcare products company)
2011 - 2018 Various Global Executive Leadership Positions, 3M Healthcare 
  Business Group (global healthcare solutions company)
  and 3M (diversified global company)
2005 - 2011 Various Global Business Leadership Positions, Medtronic 
  (global medical technology company)
Prior Various Marketing Leadership Positions, ev3 (medical
  device company)
  Various Global Marketing Leadership Positions, Boston
  Scientific (global medical technology company)
  Various Management Positions, Teleflex Medical (global 
  medical device company)
  Various Engineering Positions, GE Plastics (global 
  engineering plastics company)

Other Board Positions
iRhythm Technologies (2023-present)
CeramTec Advisory Committee (2022 – Present) 
Stanley Black and Decker (2021-present)

Notable Experience and Key Board Contributions

  • Ms. Poul has 27 years of experience in various segments of the healthcare industry.  She has a proven track record of delivering business growth and performance though portfolio transformation, value-creating innovation, and impactful capital allocation.
  • Ms. Poul has deep expertise in corporate strategy, mergers and acquisitions, global profit and loss and operations management, and commercial excellence.

M.B.A. from the University of North Carolina, Chapel Hill 
Masters in Mechanical Engineering from the University of Louisville
B.S. in Mechanical Engineering from the University of Louisville 

Andrea L. Saia
Andrea Saia Photo
Independent Director
2011 - 2012 Global Head of Alcon Vision Care, Novartis AG 
  (pharmaceutical company)
2008 - 2011 President and CEO, CibaVision Corporation, (contact lens company)
2002 - 2008 Various Positions including President of Europe, Middle East, 
  and Africa, President of the Global Lens Business and Global 
  Head of Marketing, CibaVision Corporation (contact lens company) 
  Various Positions, Unilever (consumer goods company)
Prior Various Positions, Procter & Gamble (consumer goods company)
  Various Positions, Revlon (beauty supply company)

Other Board Positions
Outset Medical, Inc. (2021-present)
LivaNova PLC (2016-2023)
Coca-Cola Enterprises, Inc. (2012-2016)

Notable Experience and Key Board Contributions

  • Ms. Saia brings 40 years of global experience within the healthcare, medical device and consumer products industries and expertise in global sales and marketing and strategic business development.  
  • Ms. Saia has worked with technologically driven companies dedicated to developing new solutions that significantly improve the health and well-being of consumers.

B.S. in Business Administration from Miami University
M.B.A. from J.L. Kellogg Graduate School of Business

Susan E. Siegel
Sue Siegel Photo
Independent Director
2017 - 2019 Chief Innovation Officer, GE (conglomerate company)
2012 - 2017 CEO, GE Ventures and Licensing (conglomerate company)
Prior General Partner, Mohr Davidow Ventures (multidisciplinary 
  investment firm; Ms. Siegel focused investments in 
  personalized medicine, life sciences and digital health)
  Director and President, Affymetrix (genomics company)

Other Board Positions
Illumina, Inc. (2019 - present)
Nevro Corporation (2020 - present)
The Engine (2016 -  2020), Chair (2020 - present) 
KFF (formerly Kaiser Family Foundation) (2019 - present)
National Venture Capital Association  (2012 - 2016) 
Pacific Biosciences, Inc. (2006 - 2013) 
Tech Interactive  (2003 - 2007)
Affymetrix (2000 - 2006)

Notable Experience and Key Board Contributions

  • Ms. Siegel brings extensive experience in identifying, funding, pioneering, and implementing industry-shifting innovations in the life sciences, biomedical research, and healthcare industries.
  • Ms. Siegel led Affymetrix, one of the fastest growing genomics companies of its time. She led it from a pre-revenue startup to a multi-billion dollar publicly listed company that helped shape the emerging genomics industry, including addressing the bioethical issues of its day. 
  • Ms. Siegel has been recognized in Fortune’s “34 Leaders Who Are Changing Health Care,” as one of “The 100 Most Influential Women in Silicon Valley,” “Fierce Biotech’s Top 10 Women in Medical Devices,” and was awarded the “Lifetime Achievement Award” by Global Corporate Venture in 2020. She is an Aspen Institute Henry Crown Fellow and is a featured “Multiplier” in the bestselling book: “Multipliers: How the Best Leaders Make Everyone Smarter.”

B.S. in Biology from the University of Puerto Rico 
M.S. in Biochemistry and Molecular Biology from Boston University Medical School. 


Data Provided by Refinitiv. Minimum 15 minutes delayed.